期刊文献+

含氟香豆素透明质酸衍生物的合成及其荧光性能 被引量:1

Synthesis and Fluorescence Properties of Hyaluronic Acid Derivatives Containing Fluorinated Coumarin
下载PDF
导出
摘要 以间氨基苯酚与三氟乙酰乙酸乙酯反应生成4-三氟甲基-7-氨基香豆素,其与氯乙酰氯反应生成4-三氟甲基-7-氯乙酰氨基香豆素。该化合物与透明质酸钠反应得到了含氟香豆素透明质酸衍生物。利用荧光光谱等分析技术研究了浓度、pH值和温度变化对该透明质酸衍生物荧光强度的影响,同时研究了金属离子对其荧光强度的影响。结果表明,一定浓度范围内,荧光强度随透明质酸衍生物浓度增大而逐渐增强;在pH值为3.86~8.85范围内,其荧光强度较为稳定;在10~80℃范围内,其荧光强度随温度的升高而逐渐减弱;在常见干扰离子存在下,Fe3+对其荧光强度有较为显著的影响,其荧光强度显著降低。这为探索透明质酸在生命机体内的药物载体机理及其靶向作用提供良好的实验基础。 4-Trifluoromethyl-7-amino coumarin obtained from m-aminophenol and ethyl trifluoroacetoacetate, further reacted with chloroacetic chloride to generate 4-trifluoromethyl-7-chloro-acetylamino coumarin. Then, the product was treated with sodium hyaluronate to give hyaluronic acid derivatives containing fluorinated coumarin. The influences of concentration, pH and temperature on fluorescence intensity of hyaluronic acid derivatives were studied. The influence of different metal ions on fluorescence intensity of hyaluronic acid derivatives was also investigated. The results show that the fluorescence intensity of hyaluronic acid derivatives is enhanced with increased concentration, kept stable when the pH ranges from 3.86 to 8.85, and decreased when temperature increased from 10 ℃ to 80 ℃. In addition, Fe^3+ leads to significantly reduced fluorescence intensity of hyaluronic acid derivatives in the presence of other interfering metal ions. These provide good experimental basis to explore the mechanism as well as the targeting behavior of hyaluronic acid as drug carrier.
出处 《应用化学》 CAS CSCD 北大核心 2014年第8期916-921,共6页 Chinese Journal of Applied Chemistry
基金 国家自然科学基金资助项目(20872051)~~
关键词 透明质酸 间氨基苯酚 荧光强度 FE^3+ hyaluronic acid, m-aminophenol, fluorescence intensity, iron ion
  • 相关文献

参考文献30

  • 1张伟,闫翠娥.透明质酸及其衍生物药物载体[J].化学进展,2006,18(12):1684-1690. 被引量:21
  • 2Benedetti L M,Topp E M,Stella V J,et al.Microspheres of Hyaluronic Acid Esters-fabrication Methods and in vitro Hydrocortisone Release[J].J Controlled Release,1990,13(1):33-41.
  • 3Kyronen K,Hume L,Benedtti L,et al.Methylprednisolone Esters of Hyaluronic Acid in Ophthalmic Drug Delivery:in vitro and in vivo Release Studies[J].Int J Phytorem,1992,80(1):161-169.
  • 4Surendrakumar K,Martyn G P,Hodgers E C M,et al.Sustained Release of Insulin from Sodium Hyaluronate Based Dry Powder Formulations after Pulmonary Delivery to Beagle Dogs[J].J Controlled Release,2003,91(3):385-394.
  • 5Luo Y,Prestwich G D.Synthesis and Selective Cytotoxicity of a Hyaluronic Acid-Antitumor Bioconjugate[J].Bioconjug Chem,1999,10(5):755-763.
  • 6Luo Y,Ziebell M R,Prestwich G D.A Hyaluronic Acid-Taxol Antitumor Bioconjugate Targeted to Cancer Cells[J].Biomacromolecules,2000,1(2):208-218.
  • 7Choi K Y,Chung H,Min K H,et al.Self-assembled Hyaluronic Acid Nanoparticles for Active Tumor Targeting[J].Biomaterials,2010,31(1):106-114.
  • 8He M,Zhao Z,Yin L,et al.Hyaluronic Acid Coated Poly(butyl cyanoacrylate) Nanoparticles as Anticancer Drug Carriers[J].Int J Pharm,2009,373(1/2):165-173.
  • 9Liu C C,Chang K Y,Wang Y J.A Novel Biodegradable Amphiphilic Diblock Copolymers Based on Poly(lactic acid) and Hyaluronic Acid as Biomaterials for Drug Delivery[J].J Polym Res,2010,17(4):459-469.
  • 10俞晨洁,张莉,李红玫,李园珂,赵震,吴非,姚静,周建平.透明质酸及其衍生物用作药物载体的研究进展[J].药学进展,2011,35(12):543-549. 被引量:6

二级参考文献69

  • 1李琦,王凤山,凌沛学,张天民.玻璃酸作为药物媒介在医药研发中的应用[J].中国药学杂志,2005,40(7):485-488. 被引量:5
  • 2于学丽,王传栋,李保陆,曹成波.透明质酸的改性及其应用[J].生物医学工程研究,2005,24(1):61-66. 被引量:17
  • 3Ekici S, Ilgin P, Yilmaza S, et al. Temperature and magnetic field responsive hyaluronic acid particles with tunable physical and chemical properties [ J ]. Appl Surf Sci, 2011,257 ( 7 ) : 2669 -2676.
  • 4Park K, Lee M Y, Kim K S, et al. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimineehyaluronic acid conjugate [ J ]. Biomaterials,2010,3! (19) :5258-5265.
  • 5Duceppe N,Tabrizian M. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/ hyaluronic acid nanoparticles [ J ]. Biomaterials, 2009,30 ( 13 ) : 2625-2631.
  • 6Platt V M, Szoka F C. Anticancer therapeutics:targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor [ J ]. Mol Pharm, 2008,5 ( 4 ) : 474-486.
  • 7Huh Y M, Cho H J, Yoon I S,et al. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride [ J ]. Eur J Pharm Sci,2010,40( 1 ) :9-15.
  • 8Liu C C, Chang K Y, Wang Y J. A novel biodegradable amphiphilic diblock copolymers based on poly (lactic acid) and hyaluronic acid as biomaterials for drug delivery[ J]. J Polym Res,2010 ,17 ( 4 ) :459-469.
  • 9He M, Zhao Z, Yin L, et al. Hyaluronic acid coated poly (butyl cyanoacrylate ) nanoparticles as anticancer drug carriers [ J ]. Int J Pharm, 2009,373 ( 1/2 ) : 165-173.
  • 10Upadhyay K K,Bhatt A,Mishra A,et al. The intracellular drug delivery and anti-tumor activity of doxorubicin loaded poly ( 3,-benzyl L-glutamate ) -b-hyaluronan polymersomes [ J]. Biomaterials ,2010,31 (10) :2882-2892.

共引文献47

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部